Nov0 Nordisk Executive Collapses During White House Announcement
Gordon Findlay, an executive at Novo Nordisk, collapsed in the Oval Office on Thursday afternoon while President Trump was unveiling a plan to lower the cost of weight-loss medications, including Ozempic.
Findlay received prompt medical assistance and was helped to his feet. Officials expect him to recover fully.
Event Details
The incident was captured on video as President Trump discussed efforts to reduce drug prices. The announcement focused on making weight-loss drugs more affordable for patients.
“Gordon Findlay of Novo Nordisk collapsed in the Oval Office Thursday afternoon as President Trump announced a plan to reduce the price of weight-loss drugs, including Ozempic.”
Related Information
- Event filmed and reported on November 6, 2025.
- The announcement was part of a broader initiative on drug pricing.
- The executive's condition is stable following the incident.
Additional Context
This occurrence coincided with several other major news events covered on November 6, including investigations and weather forecasts.
Author’s summary: Novo Nordisk executive Gordon Findlay fainted during a White House event on drug pricing but is expected to recover without complications.